Inventor · disambiguated record
Collette Behrens
Also filed as: BEHRENS COLLETTE · BEHRENS COLLETTE JANE
7 granted patents·1 pending application·33 citations·filing 2015–2022
82Inventor score
Files withTEVA PHARMACEUTICALS AUSTRALIA PTY LTD8
Top patents by PatentIndex Score
8 records- 0191US10232041B2Combination of lenalidomide and polypeptide construct, and uses thereofTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2017·Granted Mar 19, 2019·9 cites·21 claims
- 0290US9636334B2Combination of lenalidomide and polypeptide construct, and uses thereofTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2015·Granted May 2, 2017·9 cites·20 claims
- 0387US9963515B2Anti-CD38 antibodies and fusions to attenuated interferon alpha-2BTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2015·Granted May 8, 2018·5 cites·27 claims
- 0486US10544199B2Interferon alpha 2B variantsTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2015·Granted Jan 28, 2020·7 cites·20 claims
- 0583US11319356B2Interferon alpha 2B variantsTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2019·Granted May 3, 2022·2 cites·18 claims
- 0675US11117975B2Anti-CD38 antibodies and fusions to attenuated interferon alpha-2BTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2018·Granted Sep 14, 2021·1 cites·13 claims
- 0771US11253591B2Combination of lenalidomide and polypeptide construct, and uses thereofTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2019·Granted Feb 22, 2022·0 cites·17 claims
- 0869US2022220184A1Interferon alpha 2b variantsTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Collette Behrens files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →